Healthcare Solutions

May 1, 2018

Looking beyond the ‘magic bullet’ approach to drug discovery

Vanderbilt scientists have developed a new process that can rapidly and inexpensively identify personalized cancer drugs derived from nature.

By VUMC News and Communications
Elderly caucasian woman with her hands on a cane
February 12, 2018

‘Smart cane’ could one day help flag gait problems, falling risks more quickly

Falling is no joke when you’re a senior citizen or have other balance issues. Vanderbilt engineers are working on a ‘smart cane’ that could help physical therapists spot and treat problems sooner.

By VUMC News and Communications
Istock image of neurons in the brain
January 8, 2018

Vanderbilt signs licensing, research agreements to develop new approach to schizophrenia treatment

Under the terms of the licensing agreement, Lundbeck has exclusively licensed rights to compounds developed at Vanderbilt that act on a receptor in the brain that has been implicated in schizophrenia.

By Bill Snyder
Image of pain pills (iStock Photo)
November 30, 2017

Study seeks to reduce opioid use for chronic pain

Kristin Archer, PhD, DPT, associate professor and vice chair of Orthopaedics and Rehabilitation, will serve as principal investigator at Vanderbilt University Medical Center (VUMC) for a clinical trial that is examining strategies for reducing opioid use among patients with chronic pain.

By Tom Wilemon
Adult bandaging a child's knee
October 3, 2017

Cell signals that trigger wound healing are surprisingly complex

Vanderbilt scientists have taken an important step toward understanding the way in which injured cells trigger wound healing, an insight essential for improving treatments of all types of wounds.

By VUMC News and Communications
Pediatric health conditions, their treatments and the related stress hinder the prefrontal cortex, which is the region of the brain associated with learning, memory and behavior. (istock)
September 20, 2017

Goal of new tissue-chip research is to assess efficacy of novel epilepsy drugs

An interdisciplinary team of Vanderbilt University researchers has received a two-year, $2-million federal grant to develop an “organ-on-chip” model for two genetic forms of epilepsy.

By VUMC News and Communications
August 14, 2017

VUSN and VUMC researchers receive FAANP funding for Choosing Wisely collaborative study

A collaborative project between Vanderbilt University School of Nursing and Vanderbilt University Medical Center has received funding to pilot a project aimed at demonstrating the influence of nurse practitioners in reducing unnecessary testing.
By VUMC News and Communications
August 7, 2017

Vanderbilt begins Phase 1 trials of new Alzheimer’s drug

Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects.
By Bill Snyder
August 1, 2017

Smart underwear prevents back stress with just a tap

"Performance-boosting super suit" hidden under clothing can be activated by a double tap to save users' backs.
By VUMC News and Communications
June 20, 2017

How six cups of ground coffee can improve nose, throat surgery

Vanderbilt engineers have designed a “granular jamming cap” filled with coffee grounds that can improve the accuracy of the sophisticated “GPS” system that surgeons use for nose and throat surgery.
By VUMC News and Communications
April 5, 2017

Risky business

Vanderbilt investigators have developed hospital readmission models that may help prevent payment penalties to hospitals when patients are readmitted too soon after discharge.
By Paul Govern
April 3, 2017

Vanderbilt investigator lands Stand Up To Cancer grant for “smart” nanoparticles cancer research

John Wilson, Ph.D., assistant professor of Chemical and Biomolecular Engineering and of Biomedical Engineering at Vanderbilt University, has received an Innovative Research Grant from Stand Up To Cancer (SU2C). Wilson is among 10 early-career scientists to receive the grant awards focused on immuno-oncology.
March 31, 2017

A molecular clue to longevity

In budding yeast, accumulation of a certain type of RNA in the nucleus increased life span, offering a new clue to longevity.
By Laura Daniel
1 2 3 … 14